Medical Countermeasures New Mutation and DNA Repeats Behind Ceftazidime Resistance in Melioidosis BacteriumGlobal Biodefense StaffSeptember 5, 2025
Medical Countermeasures Appili Therapeutics Reports Strong Preclinical Protection from ATI-1701 Tularemia VaccineGlobal Biodefense StaffAugust 11, 2025
Medical Countermeasures Pan-Coronavirus Drug Discovery Gets a Boost from Global AI Blind ChallengeGlobal Biodefense StaffJuly 28, 2025
Tekmira Enters Phase II Ebola Clinical Study in Sierra Leone Medical Countermeasures March 11, 2015 …
New Insights on Early Stages of Bubonic Plague Infections Medical Countermeasures February 12, 2015 …